Are these companies the ASX's 2 best contrarian plays?

Down and out stars are must haves for long-term investors.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investing in great companies is a long-term pursuit.

Just like we all work hard in our jobs in the hope and expectation of better pay and conditions in the future, we all invest in companies that we believe will be better in 2, 5, 10, or 20 years' time.

Down and Out!

With this in mind, investors should consider companies that are a little unloved by the market but have the potential to deliver huge dividends and growth in the future. These companies are often found dwelling near their 12-month lows and analysts will be a little unsure as to whether they can relive their former glory.

Forgotten Stars

There are two blue-chip companies that used to be must haves for long term and income-focussed investors that have fallen out of favour in the last 12 to 18 months.

The first is Coca-Cola Amatil Ltd (ASX: CCL). Coca-Cola has disappointed investors by struggling to combat competition from Pepsi and private-label brands in Australia. This led to the CEO standing down and the appointment of Alison Watkins to the post. She is planning on refocussing the company to return it to growth but it could be a long road based on recent commentary.

Coca Cola is currently trading at around $9.40, well below its 12-month high of $13.40, and is expected to slash the dividend payout this year. If Ms. Watkins can turn the company around to the same level of profitability in 2013, Coca Cola could pay a dividend of 60 cents per share for a yield of nearly 6.4%.

My Favourite

The company with the most turnaround potential in my eyes is perennial disappointment QBE Insurance Group Ltd (ASX: QBE). QBE has been a terrible investment in recent years as it repeatedly failed to achieve forecast profitability and unveiled a swathe of problems in its US business.

The stock is up nearly 8% this month as investors have started to believe that good news will be coming soon, but the share price is still 50% below its 12-month high of $17.53. If QBE can return profitability to levels last seen in 2008, 2009, 2010, or 2011, it will have the ability to return over 120 cents per share to investors. That would correspond to a yield of up to 11% based on the current price!

Motley Fool contributor Andrew Mudie owns shares in QBE. You can find Andrew on Twitter @andrewmudie

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »